Johnson & Johnson: Dividend King in Volatile Markets
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Johnson & Johnson, a Dividend King with a 63-year streak of dividend hikes, stands out in the pharma industry. Despite losing ground to generics, theyre set to reach $100B in sales this year. Their reliable products and strong financials make them a resilient investment, with innovative medical devices and a robust dividend policy.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/319ed056247ce3c2